Top

Publications

Year	Title	Journal	Authors (First, Last)	PMID
2023	Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial.	Nat Med	Cascone T, Sepesi B	36928818
2023	Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma.	Nat Commun	Karam JA, Wood CG	37164948
2023	Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus.	Front Immunol	Lyu MA, Parmar S	37736101
2023	Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma.	Clinical Cancer Research	Osman AA, Myers JN	36689560
2023	Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancer.	Nat Commun	Parra ER, Wistuba II	37185575
2023	HER2-low expression in patients with advanced or metastatic solid tumors.	Ann Oncol.	Uzunparmak B, Dumbrava EE	37619847
2023	CRISPR–Cas9-based functional interrogation of unconventional translatome reveals human cancer dependency on cryptic non-canonical open reading frames.	Nat Struct Mol Biol	Zheng C, Chen, Y	37932451

Please remember to acknowledge the core in publications that use core services. Go to the acknowledgment page for more information.